| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |